Phase II Study to Evaluate the Efficacy of MEDI4736 in Immunological Subsets of Advanced Colorectal Cancer
Phase of Trial: Phase II
Latest Information Update: 04 Apr 2017
At a glance
- Drugs Durvalumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 14 Feb 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Jul 2018.
- 12 Jan 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Jul 2017 as reported by ClinicalTrials.gov record.
- 23 Apr 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.